Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General news updates Diplomatic crisis: Pakistan’s Consulate in Germany vandalized amid protests In a latest diplomatic incident that has escalated tensions between Pakistan and Germany, the Pakistani consulate in Frankfurt… byPallavi MadhirajuJuly 21, 2024